UnitedHealth Group (NYSE:UNH) is set to post its quarterly earnings results before the market opens on Tuesday, January 15th. Analysts expect UnitedHealth Group to post earnings of $3.22 per share for the quarter. UnitedHealth Group has set its FY 2018 guidance at $12.80-12.80 EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 EPS for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. The business had revenue of $56.56 billion for the quarter, compared to analyst estimates of $56.34 billion. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. UnitedHealth Group’s revenue for the quarter was up 12.4% on a year-over-year basis. During the same period in the prior year, the company earned $2.66 EPS. On average, analysts expect UnitedHealth Group to post $13 EPS for the current fiscal year and $15 EPS for the next fiscal year.
NYSE UNH opened at $247.67 on Friday. The company has a market cap of $234.39 billion, a P/E ratio of 24.59, a price-to-earnings-growth ratio of 1.23 and a beta of 0.88. UnitedHealth Group has a one year low of $208.48 and a one year high of $287.94. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.69 and a current ratio of 0.69.
In other news, Director Richard T. Burke sold 6,090 shares of the stock in a transaction on Wednesday, November 28th. The stock was sold at an average price of $281.72, for a total value of $1,715,674.80. Following the transaction, the director now owns 1,711,584 shares of the company’s stock, valued at approximately $482,187,444.48. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Kenneth Irwin Shine sold 163 shares of the stock in a transaction on Friday, November 9th. The shares were sold at an average price of $274.83, for a total value of $44,797.29. The disclosure for this sale can be found here. Corporate insiders own 0.87% of the company’s stock.
A number of equities research analysts recently commented on the company. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $305.00 price target on the stock in a research report on Friday, December 14th. BMO Capital Markets increased their price target on UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a research report on Thursday, October 18th. Cleveland Research restated a “buy” rating on shares of UnitedHealth Group in a research report on Friday. Oppenheimer upped their price objective on UnitedHealth Group from $276.00 to $295.00 and gave the stock an “outperform” rating in a report on Wednesday, October 17th. Finally, Piper Jaffray Companies upped their price objective on UnitedHealth Group to $300.00 and gave the stock an “overweight” rating in a report on Wednesday, October 17th. One investment analyst has rated the stock with a hold rating and twenty-two have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $294.20.
ILLEGAL ACTIVITY NOTICE: This report was first posted by Zolmax and is owned by of Zolmax. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at https://zolmax.com/investing/unitedhealth-group-unh-to-release-earnings-on-tuesday/2821561.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Diversification in Investing
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.